Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07533877 · ClinicalTrials.gov registry record · NA
Testing Ultra-processed Warning Labels in United States
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 7,000
- Enrollment target
NCT07533877: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT07533877 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 7,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (399% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07533877, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,000 participants
- Enrollment target
Study Summary
This randomized controlled online experiment will test whether adding an ultra-processed food (UPF) warning label to the FDA's proposed Nutrition Information Box (NIB) changes consumer perceptions of UPFs among a nationally representative sample of U.S. adults. Participants will be randomized to one of four label conditions and will evaluate four UPF yogurt products with different nutritional profiles on the NIB. The primary outcome is purchase intent and the secondary outcomes are perceived healthfulness, perceived usefulness and correct identification of UPF products. This experiment aims to answer the following questions: Do UPF warning labels reduce purchase intentions compared to the NIB alone? Do UPF warning labels reduce perceived healthfulness compared to the NIB alone? Do UPF warning labels help more consumers correctly identify products as ultra-processed compared to the NIB alone? Do different UPF warning label color designs differ in effectiveness at reducing purchase intentions, lowering perceived healthfulness, and improving correct identification of UPFs? Researchers will compare outcomes across the four randomized arms to estimate the independent effect of adding UPF warnings beyond nutrient disclosure in the NIB alone.
Primary Outcome
Likelihood of purchasing each product measured on a 5-point Likert scale from 1 = "Very unlikely" to 5 = "Very likely" indicating how likely the participant would be to buy the product in the next week if it were available in a store. Higher scores indicate greater purchase intent.
Interventions
- BEHAVIORAL Label exposure in mock-up UPF products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 2026-04-13 |
| Est. Completion | 2026-05-04 |
| Phase | NA |
What the finished NCT07533877 record still lists
NCT07533877 is an interventional study that assigns participants to a tested intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (399% higher).
The record links to 0 conditions, and to 1 intervention - of which Label exposure in mock-up UPF products is the first listed.
NCT07533877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07533877 about?
NCT07533877 is a clinical study titled "Testing Ultra-processed Warning Labels in United States". This randomized controlled online experiment will test whether adding an ultra-processed food (UPF) warning label to the FDA's proposed Nutrition Information Box (NIB) changes consumer perceptions of UPFs among a nationally representative sample of U.S. adults. Participants will be randomized to on...
What is the current status of trial NCT07533877?
This trial is currently completed. It is a NA study. The enrollment target is 7,000 participants. The study started on 2026-04-13. Estimated completion is 2026-05-04.
What interventions are being tested in trial NCT07533877?
The interventions under investigation include: Label exposure in mock-up UPF products (BEHAVIORAL).
Who is sponsoring clinical trial NCT07533877?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07533877's enrollment target sits among peer trials
7,000 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI